Valuation: Diaceutics PLC

Market Cap 112M 148M 130M 122M 209M 14.22B 214M 1.44B 565M 7.04B 557M 545M 24.33B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 104M 138M 121M 113M 195M 13.23B 199M 1.34B 525M 6.55B 519M 507M 22.64B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.77x
Free-Float
71.95%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
3 months+19.76%
6 months+19.76%
Current year+46.28%
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.34
Extreme 1.338
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 55 01/10/2023
Chairman 65 01/10/2024
Director/Board Member 42 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 142M
-12.65%-32.06%+194.09%+641.10% 43.45B
-1.15%+5.35% - - 6.95B
-4.66%-4.13% - - 3.36B
+0.35%-5.94%-1.42%+20.35% 3.2B
+0.75%-7.94%+7.71%+104.41% 3.05B
+2.55%+2.85%-36.85%-40.71% 1.28B
+1.56%-0.31%-15.98%-39.42% 1.28B
+0.33%-14.63%-42.15%+37.43% 1.22B
Average -1.62%-0.33%+17.57%+120.53% 7.97B
Weighted average by Cap. -8.57%+2.42%+155.79%+526.90%

Financials

2026 *2027 *
Net sales 46.72M 62.07M 54.54M 50.91M 87.45M 5.94B 89.61M 604M 236M 2.94B 233M 228M 10.17B 56.34M 74.85M 65.77M 61.39M 105M 7.17B 108M 728M 285M 3.55B 281M 275M 12.26B
Net income -1.1M -1.46M -1.28M -1.2M -2.06M -140M -2.11M -14.21M -5.56M -69.26M -5.49M -5.37M -239M 1.5M 1.99M 1.75M 1.63M 2.81M 191M 2.88M 19.38M 7.58M 94.45M 7.48M 7.32M 327M
Net Debt -7.78M -10.34M -9.08M -8.48M -14.56M -990M -14.92M -101M -39.31M -490M -38.81M -37.96M -1.69B -12.1M -16.07M -14.12M -13.18M -22.64M -1.54B -23.2M -156M -61.13M -762M -60.34M -59.03M -2.63B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.265GBP
Average target price
2.130GBP
Spread / Average Target
+68.38%

Quarterly revenue - Rate of surprise